Diabetes Complications Affecting the Eye

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2026-08-21
EMA Authorised: Eylea (aflibercept) — Bayer AG
EMA authorises Eylea (aflibercept) for multiple ocular conditions including wet age-related macular degeneration and diabetic eye diseases.